There are a number of hazardous chemicals commonly used in biomedical research for which a biological use application (BUA) is required. These include carcinogens, chemotherapy agents, toxins of biological origin, and other chemicals that are deemed hazardous by the IBC, biosafety, or another authority. Biosafety performs a risk assessment and requires an exposure control plan or SOP for these agents. When there is a medical intervention that can be applied prior to exposure or a process for medical care upon exposure that can be developed ahead of time, the Occupational Medicine Program provides access to it for employees.
Not all chemicals used in biomedical research have a prophylactic measure such as an immunization. However, all chemical exposures, even small ones, must be reported to one’s supervisor. The supervisor is responsible to complete a manager’s incident report and to ensure that an injured employee seeks medical attention promptly.
BUA-Required Chemical Pre- and Post-Exposure Processes
Chemical | Research Role | Pre-Exposure Process | Post-Exposure Process |
---|---|---|---|
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | A neurotoxin that causes Parkinson’s-like symptoms |
|
|
ENU N-ethyl-N-nitrosourea | Potent mutagen |
|
|
Pertussis toxin Diphtheria toxin Tetanus toxin |
|
|
|
Other toxins of biological origin, e.g. Tetrodotoxin Conotoxin, SEB, others |
Various uses in biomedical research |
|
|
Carcinogens (Prop 65 list) |
Various uses in biomedical research |
|
|
Chemotherapy agents | Various uses in biomedical research |
|
|
Streptozoticin | Induces diabetes in mice |
|
|
Pertussis toxin Diphtheria toxin Tetanus toxin |
|
|
|
Other toxins of biological origin, e.g. Tetrodotoxin Conotoxin, SEB, others |
Various uses in biomedical research |
|
|